e -p r o o fPost-implementation pharmacist surveys were conducted, and flowsheet data from 07/05/2022-01/31/2025 was extracted.A descriptive analysis was completed. ResultsAll pharmacists (n=5) using the flowsheet completed a post-implementation survey.Overall satisfaction with the flowsheet was high 9.2 (scale of 0-10, 0=strongly dissatisfied and 10=strongly satisfied).All pharmacists strongly agreed (80%, n=4) or agreed (20%, n=1) the flowsheet increased visibility into patient's treatment status and strongly agreed (60%) or agreed (40%) that the flowsheet streamlined workflow.Post-implementation, previously unavailable data was pulled from the EHR.This allowed reporting of time from referral to first infusion dose median 22 (interquartile range 15, 35) days and capture rate for the institution's infusion centers (66%) and specialty pharmacy (52%). ConclusionImplementing a flowsheet with alerts to manage patients initiating biologics for IBD that require infusion(s) before switching to SC dosing streamlined workflow, increased visibility, and improved data capture.
Fann et al. (Sun,) studied this question.